李战

Zhan Li obtained a bachelor’s degree in pharmacology from China Pharmaceutical University in 1994 and a master’s degree in business administration from Asia International Open University in Macao in 2000. Mr. Li was awarded second prize for scientific and technological advancement by the Nanjing Municipal People’s Government， Jiangsu Province， the PRC in 2001. Mr. Li has over 10 years’ experience in the research and development of pharmaceutical products to treat diseases of the kidney and liver. Mr. Li used to be an instructor at China Pharmaceutical University and employed by Jiangsu Pharmaceutical as a technical manager where Mr. Li was responsible for research on new pharmaceutical products and development of pharmacology. During the employment at China Pharmaceutical University from 1994 to 1996， Mr. Li taught pharmacology and undertook research and development projects and published articles in respect of his studies relating to diseases of the kidney and liver in the China Pharmaceutical University publications. Mr. Li joined C&O Pharmaceutical Technology （Holdings） Limited in 2001 and was appointed as the Executive Director on 12 August 2005 and also the general manager of Nanjing Changao R&D. Mr. Li is responsible for overseeing the research and development of new pharmaceutical products for the Group.